This webcast with PRA Health Sciences' Jacinta Aniagolu-Johnson (Senior Director, Safety and Risk Management) explores how a well defined signal process adds critical value to risk assessment and risk management.
Explore related content and topics
Fact Sheet
Pharmacogenomics (PGx) Fact Sheet
Pharmacogenomics aims to develop rational means to optimize drug therapy with respect to the patient’s genotype, ensuring maximum drug efficiency…
View Resource
White Paper
Local Representation: What Clinical Trial Sponsors Need to Know
In this white paper, best practices are described as well as required Sponsor/Local Representative agreement areas. It is important that major…
View Resource
White Paper
PBRERs – Pitfalls and Misconceptions
Following the release of ICH guideline E2C (R2) Step 5 on the Periodic Benefit-Risk Evaluation Report (PBRER) in January 2013 and EU GVP Module VII –…
View Resource
View all related content and resources for Pharmacovigilance
Explore Insights